Response to 'NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors' by Xiang-Yu Meng
Saved in:
| Main Authors: | David A Schoenfeld, Jasmine I Caulfield, Lilach Aizenbud, Ana Luisa Perdigoto, Matthew R Austin, Jacqueline E Mann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-06-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/11/6/e007397.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IgE Immune Complexes Mitigate Eosinophilic Immune Responses through NLRC4 Inflammasome
by: Ece Oylumlu, et al.
Published: (2023-01-01) -
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
by: Min Li, et al.
Published: (2025-03-01) -
Role of NLRC3 in modulating inflammatory responses in neonates
by: Meng Zhang, et al.
Published: (2025-05-01) -
The Intensity of Radiotherapy-Elicited Immune Response Is Associated with Esophageal Cancer Clearance
by: Jin-lu Ma, et al.
Published: (2014-01-01) -
Epigenetic modulation elicits an NK cell-mediated immune response in urothelial carcinoma
by: Himani Kumari, et al.
Published: (2025-06-01)